Difference between revisions of "Diabetes UK"
Mira Purska (talk | contribs) |
Mira Purska (talk | contribs) |
||
Line 2: | Line 2: | ||
Diabetes UK uses services of [[Ipsos MORI]]<ref>http://www.diabetes.org.uk/Documents/About%20Us/Financial%20Statement06FINAL.pdf</ref>. | Diabetes UK uses services of [[Ipsos MORI]]<ref>http://www.diabetes.org.uk/Documents/About%20Us/Financial%20Statement06FINAL.pdf</ref>. | ||
Although there is no disclosure of the corporate sponsorship in the annual financial reports and the website of Diabetes UK, it's connection to the pharmaceutical industry is more explicit on the [[Strategic Alliance]] website.<ref>http://www.diabetesplanning.org</ref> It is the alliance between pharmaceutical companies such as [[Sanofi-Aventis]], [[GSK]], [[Pfizer]] and Diabetes UK. | Although there is no disclosure of the corporate sponsorship in the annual financial reports and the website of Diabetes UK, it's connection to the pharmaceutical industry is more explicit on the [[Strategic Alliance]] website.<ref>http://www.diabetesplanning.org</ref> It is the alliance between pharmaceutical companies such as [[Sanofi-Aventis]], [[GSK]], [[Pfizer]] and Diabetes UK. | ||
− | According to its website The Strategic Alliance "was established to explore potential joint initiatives that would drive delivery of diabetes policy in order to enhance the quality of diabetes care & improve outcomes for people with diabetes." <ref>http://www.diabetesplanning.org/index.php?country=3</ref> | + | According to its website The Strategic Alliance "was established to explore potential joint initiatives that would drive delivery of diabetes policy in order to enhance the quality of diabetes care & improve outcomes for people with diabetes." <ref>http://www.diabetesplanning.org/index.php?country=3</ref> The representative of the charity Bridget Turner described the allliance as being free of commercial interest, "a non-commercial body with labour/funding contributed equally in a four way split between the three pharma companies and the charity".<ref>[http://www.apmhealtheurope.com/story.php?mots=WEBSITE&searchScope=1&searchType=0&numero=1992 New UK charity/pharma funded diabetes website aims to raise disease awareness and funding] APM Health Europe, March 30, 2006</ref> |
+ | |||
+ | |||
+ | |||
=='Corporate Partners'== | =='Corporate Partners'== |
Revision as of 16:32, 7 February 2008
Diabetes UK is the charity working for "people with diabetes, funding research, campaigning and helping people live with the condition. [...]We represent the interests of people with diabetes by lobbying the government for better standards of care and the best quality of life. Diabetes UK spends up to £6.5 million on research...".[1] Diabetes UK uses services of Ipsos MORI[2]. Although there is no disclosure of the corporate sponsorship in the annual financial reports and the website of Diabetes UK, it's connection to the pharmaceutical industry is more explicit on the Strategic Alliance website.[3] It is the alliance between pharmaceutical companies such as Sanofi-Aventis, GSK, Pfizer and Diabetes UK. According to its website The Strategic Alliance "was established to explore potential joint initiatives that would drive delivery of diabetes policy in order to enhance the quality of diabetes care & improve outcomes for people with diabetes." [4] The representative of the charity Bridget Turner described the allliance as being free of commercial interest, "a non-commercial body with labour/funding contributed equally in a four way split between the three pharma companies and the charity".[5]
'Corporate Partners'
Eli Lilly and Company Limited
Affiliations
Pharmaceutical Services Negotiating Committee
Notes
- ↑ http://www.diabetes.org.uk/About_us/How-we-are-governed/Legal-and-financial-information/Report_and_financial_information/
- ↑ http://www.diabetes.org.uk/Documents/About%20Us/Financial%20Statement06FINAL.pdf
- ↑ http://www.diabetesplanning.org
- ↑ http://www.diabetesplanning.org/index.php?country=3
- ↑ New UK charity/pharma funded diabetes website aims to raise disease awareness and funding APM Health Europe, March 30, 2006